Pharmafile Logo

ReSearch Pharmaceutical Services

RPS provides comprehensive global Phase I-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries. The company has operations in 45 countries across Europe, the Americas, Asia-Pacific and Africa.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

520 Virginia Drive, Fort Washington, PA 19034, USA
+1 215 540 0700

 Latest Content from PMHub 

5 Healthcare Marketing Blunders | How To Avoid Them.

Here are 5 healthcare marketing blunders and how best to avoid them.

Design Trends We’ve Seen In 2022

Our graphic designer Isla takes a deep dive into the graphic design trends we’ve seen in 2022 and what to expect throughout 2023 and beyond.

Rare diseases: making a difference through education

Press Releases | September 28, 2022 | Medscape Education

Medscape Education team up with The Guardian to launch a Rare Disease campaign in the UK.

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment

Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?

Value is in the eye of the customer. Co-creation is a bridge to value.

White Papers and Resources | September 27, 2022 | nzyme

We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning.  Our interviews reveal important insights about the tensions between...

Leading pharmaceutical executive Jennifer Fillman joins evidence-based solution provider Genesis Research as Chief Financial Officer

Press Releases | September 27, 2022 | Genesis Research Group

International health economics and outcomes research (HEOR) and real-world evidence (RWE) organization Genesis Research has announced the appointment of Jennifer Fillman as its new Chief Financial Officer. Prior to joining...

Partnering with Patients and Caregivers in Clinical Research

One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person...

Practical advice for Early Scientific Advice (ESA) in HTA submissions

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence...